Airain Ltd’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-16,162
Closed -$1.3M 971
2017
Q1
$1.3M Sell
16,162
-213,083
-93% -$16.6M 0.06% 296
2016
Q4
$16.3M Buy
229,245
+64,495
+39% +$5.07M 1.32% 11
2016
Q3
$14.2M Buy
164,750
+112,295
+214% +$9.79M 0.84% 19
2016
Q2
$4.55M Sell
52,455
-142,621
-73% -$11.5M 0.26% 115
2016
Q1
$14.6M Buy
+195,076
New +$14.7M 1.01% 13
2015
Q4
Sell
-6,924
Closed -$463K 964
2015
Q3
$463K Sell
6,924
-26,609
-79% -$1.96M 0.03% 485
2015
Q2
$2.48M Buy
+33,533
New +$2.56M 0.14% 182
2014
Q1
Sell
-27,831
Closed -$1.6M 796
2013
Q4
$1.6M Buy
+27,831
New +$1.58M 0.21% 127
2013
Q3
Sell
-7,961
Closed -$410K 590
2013
Q2
$410K Buy
+7,961
New +$394K 0.06% 309

Other funds holding MDT

Airain Ltd's MDT Position: Q2 2017 in Review

Airain Ltd sold out of Medtronic (MDT) in Q2 2017, closing a stake of 16,162 shares — an estimated $1.3M sold.

Airain Ltd first reported a position in MDT in Q2 2013 and held it in 9 quarters. The position peaked at $16.3M in Q4 2016. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Airain Ltd reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 16,162 Medtronic shares in Q2 2017, an estimated $1.3M.
  • Airain Ltd first reported a position in Medtronic in Q2 2013 and held it in 9 quarters.
  • Airain Ltd's Medtronic position peaked at $16.3M in Q4 2016.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.